{"id":"https://openalex.org/W2132002674","doi":"https://doi.org/10.1111/j.1360-0443.1991.tb01859.x","title":"Follow\u2010up after a six\u2010month maintenance period on naltrexone versus placebo in heroin addicts","display_name":"Follow\u2010up after a six\u2010month maintenance period on naltrexone versus placebo in heroin addicts","alternate_titles":[],"publication_year":1991,"publication_date":"1991-08-01","ids":{"openalex":"https://openalex.org/W2132002674","doi":"https://doi.org/10.1111/j.1360-0443.1991.tb01859.x","mag":"2132002674","pmid":"https://pubmed.ncbi.nlm.nih.gov/1912753"},"language":"en","primary_location":{"id":"doi:10.1111/j.1360-0443.1991.tb01859.x","doi":"https://doi.org/10.1111/j.1360-0443.1991.tb01859.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.1991.tb01859.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210197271","display_name":"British Journal of Addiction","issn_l":"0952-0481","issn":["0952-0481","2056-5178"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Addiction","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2132002674"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"L. SAN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. SAN","raw_affiliation_strings":["Secci\u00f3n de Toxicoman\u00edas, Hospital del Mar, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secci\u00f3n de Toxicoman\u00edas, Hospital del Mar, Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015539471","display_name":"G. POMAROL","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. POMAROL","raw_affiliation_strings":["Sectio\u0301n de Toxicomani\u0301as, Hospital del Mar","Secti\u00f3n de Toxicoman\u00edas, Hospital del Mar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sectio\u0301n de Toxicomani\u0301as, Hospital del Mar","institution_ids":["https://openalex.org/I4210130874"]},{"raw_affiliation_string":"Secti\u00f3n de Toxicoman\u00edas, Hospital del Mar","institution_ids":["https://openalex.org/I4210130874"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109767111","display_name":"J\u00e9r\u00f4me Peri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. M. PERI","raw_affiliation_strings":["Sectio\u0301n de Toxicomani\u0301as, Hospital del Mar","Secti\u00f3n de Toxicoman\u00edas, Hospital del Mar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sectio\u0301n de Toxicomani\u0301as, Hospital del Mar","institution_ids":["https://openalex.org/I4210130874"]},{"raw_affiliation_string":"Secti\u00f3n de Toxicoman\u00edas, Hospital del Mar","institution_ids":["https://openalex.org/I4210130874"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046743200","display_name":"J. M. OLLE","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. M. OLLE","raw_affiliation_strings":["Sectio\u0301n de Toxicomani\u0301as, Hospital del Mar","Secti\u00f3n de Toxicoman\u00edas, Hospital del Mar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sectio\u0301n de Toxicomani\u0301as, Hospital del Mar","institution_ids":["https://openalex.org/I4210130874"]},{"raw_affiliation_string":"Secti\u00f3n de Toxicoman\u00edas, Hospital del Mar","institution_ids":["https://openalex.org/I4210130874"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009505500","display_name":"Jordi Cam\u00ed","orcid":"https://orcid.org/0000-0002-5720-769X","observed_orcids":["https://orcid.org/0000-0002-5720-769X"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. CAMI","raw_affiliation_strings":["Institut Municipal d'Investigacio\u0301 Me\u0300dico, Universitat Auto\u0300noma, Barcelona, Spain","Institut Municipal d'Investigaci\u00f3 M\u00e8dico, Universitat Aut\u00f2noma, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Municipal d'Investigacio\u0301 Me\u0300dico, Universitat Auto\u0300noma, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942"]},{"raw_affiliation_string":"Institut Municipal d'Investigaci\u00f3 M\u00e8dico, Universitat Aut\u00f2noma, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5009505500"],"corresponding_institution_ids":["https://openalex.org/I123044942"],"apc_list":null,"apc_paid":null,"fwci":2.9845,"has_fulltext":false,"cited_by_count":85,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90304289,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"86","issue":"8","first_page":"983","last_page":"990"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.019500000402331352,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/heroin-dependence","display_name":"heroin addiction","score":0.9150000214576721},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.996999979019165},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.5669999718666077},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.8420000076293945},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.8109999895095825},{"id":"https://openalex.org/keywords/treatment-acceptance","display_name":"treatment acceptance","score":0.5569999814033508},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5649999976158142},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6570000052452087},{"id":"https://openalex.org/keywords/adjuvant-pharmacotherapy","display_name":"adjuvant pharmacotherapy","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.9602335095405579},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7989821434020996},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.71524977684021},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.665285050868988},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5951134562492371},{"id":"https://openalex.org/C3019590667","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonist","level":5,"score":0.5856946110725403},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.48114073276519775},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46350568532943726},{"id":"https://openalex.org/C2778399450","wikidata":"https://www.wikidata.org/wiki/Q412221","display_name":"Clonidine","level":2,"score":0.44058844447135925},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40286532044410706},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2357792854309082},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.18780657649040222},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1360-0443.1991.tb01859.x","doi":"https://doi.org/10.1111/j.1360-0443.1991.tb01859.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.1991.tb01859.x","pdf_url":null,"source":{"id":"https://openalex.org/S4210197271","display_name":"British Journal of Addiction","issn_l":"0952-0481","issn":["0952-0481","2056-5178"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Addiction","raw_type":"journal-article"},{"id":"pmid:1912753","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1912753","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of addiction","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1976759560","https://openalex.org/W2004951442","https://openalex.org/W2016260469","https://openalex.org/W2029768843","https://openalex.org/W2042017134","https://openalex.org/W2043249246","https://openalex.org/W2061017106","https://openalex.org/W2076116464","https://openalex.org/W2091052211","https://openalex.org/W2096729002","https://openalex.org/W2161755544","https://openalex.org/W2167195669","https://openalex.org/W2242530628","https://openalex.org/W2268367084","https://openalex.org/W2898042322","https://openalex.org/W4210957923","https://openalex.org/W4234965251","https://openalex.org/W4242997071"],"related_works":["https://openalex.org/W2993205759","https://openalex.org/W1990391721","https://openalex.org/W4236082527","https://openalex.org/W2068113188","https://openalex.org/W2079969215","https://openalex.org/W2145366493","https://openalex.org/W2030028793","https://openalex.org/W1980958049","https://openalex.org/W2911676331","https://openalex.org/W2028889668"],"abstract_inverted_index":{"Naltrexone":[0],"and":[1,42,86,159,186],"placebo":[2,120,172],"as":[3,173],"adjuvant":[4],"treatment":[5,30,114,126],"of":[6,29,33,39,49,52,105,156,164,171,181],"opioid":[7,66,185],"dependence":[8,67],"were":[9,68,110,152,175],"compared":[10],"in":[11,17,35,70,128,149,154,179],"a":[12,100,124,129],"double-blind,":[13],"controlled":[14],"clinical":[15],"trial":[16],"50":[18,50],"heroin":[19,36],"addicts.":[20],"The":[21,162],"overall":[22,43],"efficacy":[23,163],"was":[24,166],"assessed":[25],"by":[26],"the":[27,71,103,106,136,144],"degree":[28],"acceptance,":[31],"percentage":[32],"relapse":[34],"consumption,":[37,189],"presence":[38],"side":[40,193],"effects,":[41],"retention":[44,183],"on":[45,79,88],"naltrexone.":[46],"A":[47],"total":[48],"patients":[51,74,109,142],"both":[53,150],"sexes,":[54],"aged":[55],"from":[56],"18":[57],"to":[58,113,169],"30":[59],"years,":[60],"who":[61],"fulfilled":[62],"DSM-III-R":[63],"criteria":[64],"for":[65,83,99],"included":[69],"study.":[72],"All":[73],"completed":[75],"detoxification":[76],"with":[77,115],"clonidine":[78],"an":[80,89],"inpatient":[81],"basis":[82],"2":[84],"weeks":[85],"subsequently,":[87],"out-patient":[90],"basis,":[91],"received":[92],"oral":[93],"naltrexone":[94,116,165],"(350":[95],"mg":[96],"per":[97],"week)":[98],"month.":[101],"At":[102],"beginning":[104],"second":[107],"month":[108],"randomly":[111],"allocated":[112],"(28":[117],"patients)":[118,122],"or":[119,192],"(22":[121],"until":[123],"6-month":[125],"period":[127,138],"double-blind":[130],"fashion":[131],"had":[132],"been":[133],"completed.":[134],"During":[135],"study":[137],"(1":[139],"year)":[140],"all":[141],"followed":[143],"same":[145],"therapeutic":[146],"schedule.":[147],"Patients":[148],"groups":[151],"comparable":[153],"terms":[155],"socio-demographic":[157],"data":[158],"toxicological":[160],"history.":[161],"not":[167],"superior":[168],"that":[170],"there":[174],"no":[176],"significant":[177],"differences":[178],"acceptance":[180],"treatment,":[182],"rates,":[184],"other":[187],"drug":[188,190],"compliance":[191],"effects.":[194]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2132002674","counts_by_year":[{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
